Therapeutics: Tumor necrosis factor receptor superfamily member 4 (OX40; TNFRSF4; CD134)

Autoimmune disease

INDICATION: Multiple sclerosis (MS)

Mouse studies suggest agonizing OX40 could help treat MS. In

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE